Vermillion Debt to Equity Ratio 2006-2018 | VRML

Current and historical debt to equity ratio values for Vermillion (VRML) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Vermillion debt/equity for the three months ending September 30, 2018 was 0.14.
Vermillion Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.01B 0.14
2018-06-30 $0.00B $0.01B 0.12
2018-03-31 $0.00B $0.00B 1.16
2017-12-31 $0.00B $0.00B 0.44
2017-09-30 $0.00B $0.01B 0.26
2017-06-30 $0.00B $0.01B 0.34
2017-03-31 $0.00B $0.01B 0.24
2016-12-31 $0.00B $0.00B 0.44
2016-09-30 $0.00B $0.01B 0.27
2016-06-30 $0.00B $0.01B 0.19
2016-03-31 $0.00B $0.01B 0.00
2015-12-31 $0.00B $0.02B 0.00
2015-09-30 $0.00B $0.02B 0.00
2015-06-30 $0.00B $0.01B 0.00
2015-03-31 $0.00B $0.02B 0.00
2014-12-31 $0.00B $0.02B 0.00
2014-09-30 $0.00B $0.01B 0.00
2014-06-30 $0.00B $0.02B 0.00
2014-03-31 $0.00B $0.02B 0.00
2013-12-31 $0.00B $0.03B 0.00
2013-09-30 $0.00B $0.01B 0.00
2013-06-30 $0.00B $0.01B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.01B 0.00
2012-09-30 $0.00B $0.01B 0.00
2012-06-30 $0.00B $0.01B 0.00
2012-03-31 $0.00B $0.01B 0.00
2011-12-31 $0.00B $0.01B 0.00
2011-09-30 $0.01B $0.01B 0.53
2011-06-30 $0.01B $0.02B 0.40
2011-03-31 $0.01B $0.02B 0.32
2010-12-31 $0.01B $0.01B 1.52
2010-09-30 $0.01B $0.00B 1.56
2010-06-30 $0.00B $0.00B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.01B $-0.03B -0.37
2009-09-30 $0.00B $0.00B 0.00
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.03B $-0.03B -1.06
2008-06-30 $0.03B $-0.02B -1.28
2008-03-31 $0.03B $-0.02B -1.59
2007-12-31 $0.03B $-0.01B -2.29
2007-09-30 $0.03B $-0.01B -3.23
2007-06-30 $0.03B $-0.02B -1.28
2007-03-31 $0.03B $-0.02B -1.73
2006-12-31 $0.03B $-0.01B -2.57
2006-09-30 $0.04B $-0.01B -2.91
2006-06-30 $0.03B $-0.01B -6.12
2006-03-31 $0.03B $0.00B 20.96
2005-12-31 $0.03B $0.01B 4.77
2005-09-30 $0.03B $0.02B 1.89
2005-06-30 $0.03B $0.01B 3.31
2005-03-31 $0.03B $0.02B 1.63
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.060B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $101.647B 22.71
Intuitive Surgical (ISRG) United States $62.797B 59.11
Edwards Lifesciences (EW) United States $37.165B 37.83
Fresenius Medical Care AG KGaA (FMS) Germany $23.805B 16.09
IDEXX Laboratories (IDXX) United States $18.131B 49.24
ABIOMED (ABMD) United States $16.324B 107.76
Hologic (HOLX) United States $13.485B 20.39
DexCom (DXCM) United States $13.193B 0.00
Teleflex (TFX) United States $13.146B 29.84
Varian Medical Systems (VAR) United States $12.050B 30.10
STERIS (STE) United Kingdom $10.343B 26.58
Masimo (MASI) United States $6.869B 44.54
Penumbra (PEN) United States $5.368B 324.10
LivaNova (LIVN) United Kingdom $4.892B 31.40
Globus Medical (GMED) United States $4.712B 29.54
Integra LifeSciences Holdings (IART) United States $4.349B 21.19
Wright Medical Group (WMGI) Netherlands $3.986B 0.00
Cantel Medical (CMD) United States $3.532B 34.83
Inogen (INGN) United States $3.029B 65.39
Tandem Diabetes Care (TNDM) United States $2.955B 0.00
Integer Holdings (ITGR) United States $2.678B 22.41
Glaukos (GKOS) United States $2.417B 0.00
AVANOS MEDICAL, INC (AVNS) United States $2.298B 20.71
OPKO Health (OPK) United States $1.677B 0.00
Nevro (NVRO) United States $1.462B 0.00
Tactile Systems Technology (TCMD) United States $1.305B 207.82
ORTHOFIX MEDICAL INC (OFIX) United States $1.220B 35.25
Luminex (LMNX) United States $1.161B 53.14
Accelerate Diagnostics (AXDX) United States $1.073B 0.00
Pacific Biosciences Of California (PACB) United States $1.067B 0.00
Intersect ENT (XENT) United States $1.019B 0.00
CryoLife (CRY) United States $0.999B 108.12
Natus Medical (BABY) United States $0.922B 19.24
Mesa Laboratories (MLAB) United States $0.897B 36.71
AngioDynamics (ANGO) United States $0.871B 28.26
ViewRay (VRAY) United States $0.765B 0.00
Veracyte (VCYT) United States $0.754B 0.00
AxoGen (AXGN) United States $0.673B 0.00
Quotient (QTNT) Switzerland $0.632B 0.00
OrthoPediatrics (KIDS) United States $0.475B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.445B 0.00
Si-Bone (SIBN) United States $0.438B 0.00
Accuray (ARAY) United States $0.433B 0.00
Fluidigm (FLDM) United States $0.405B 0.00
Pulse Biosciences (PLSE) United States $0.372B 0.00
GenMark Diagnostics (GNMK) United States $0.353B 0.00
Neuronetics (STIM) United States $0.316B 0.00
SeaSpine Holdings (SPNE) United States $0.304B 0.00
Sientra (SIEN) United States $0.298B 0.00
RTI Surgical (RTIX) United States $0.298B 47.80
IRadimed (IRMD) United States $0.290B 61.72
Nuvectra (NVTR) United States $0.247B 0.00
Helius Medical Technologies (HSDT) United States $0.179B 0.00
T2 Biosystems (TTOO) United States $0.163B 0.00
Ekso Bionics Holdings (EKSO) United States $0.137B 0.00
Sensus Healthcare (SRTS) United States $0.121B 0.00
Ra Medical Systems (RMED) United States $0.093B 0.00
Titan Medical (TMDI) Canada $0.093B 0.00
Biosig Technologies (BSGM) United States $0.085B 0.00
EDAP TMS (EDAP) France $0.082B 0.00
ConforMIS (CFMS) United States $0.080B 0.00
Apollo Endosurgery (APEN) United States $0.074B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.067B 0.00
Alphatec Holdings (ATEC) United States $0.061B 0.00
Second Sight Medical Products (EYES) United States $0.056B 0.00
OBALON THERPTCS (OBLN) United States $0.049B 0.00
Microbot Medical (MBOT) United States $0.038B 0.00
Viveve Medical (VIVE) United States $0.034B 0.00
Restoration Robotics (HAIR) United States $0.031B 0.00
PAVmed (PAVM) United States $0.027B 0.00
DarioHealth (DRIO) Israel $0.025B 0.00
Lianluo Smart (LLIT) China $0.024B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
Neovasc (NVCN) Canada $0.019B 0.00
Dynatronics (DYNT) United States $0.018B 0.00
Bioanalytical Systems (BASI) United States $0.014B 45.67
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Avinger (AVGR) United States $0.010B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Atossa Genetics (ATOS) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00